These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 19104661)

  • 1. Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes.
    Ren YR; Pan F; Parvez S; Fleig A; Chong CR; Xu J; Dang Y; Zhang J; Jiang H; Penner R; Liu JO
    PLoS One; 2008; 3(12):e4009. PubMed ID: 19104661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lovastatin blocks Kv1.3 channel in human T cells: a new mechanism to explain its immunomodulatory properties.
    Zhao N; Dong Q; Qian C; Li S; Wu QF; Ding D; Li J; Wang BB; Guo KF; Xie JJ; Cheng X; Liao YH; Du YM
    Sci Rep; 2015 Nov; 5():17381. PubMed ID: 26616555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxins Targeting the Kv1.3 Channel: Potential Immunomodulators for Autoimmune Diseases.
    Zhao Y; Huang J; Yuan X; Peng B; Liu W; Han S; He X
    Toxins (Basel); 2015 May; 7(5):1749-64. PubMed ID: 25996605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acacetin blocks kv1.3 channels and inhibits human T cell activation.
    Zhao N; Dong Q; Fu XX; Du LL; Cheng X; Du YM; Liao YH
    Cell Physiol Biochem; 2014; 34(4):1359-72. PubMed ID: 25301362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous animal toxin-like human β-defensin 2 inhibits own K(+) channels through interaction with channel extracellular pore region.
    Yang W; Feng J; Xiang F; Xie Z; Zhang G; Sabatier JM; Cao Z; Li W; Chen Z; Wu Y
    Cell Mol Life Sci; 2015 Feb; 72(4):845-53. PubMed ID: 25238780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18β-Glycyrrhetinic acid potently inhibits Kv1.3 potassium channels and T cell activation in human Jurkat T cells.
    Fu XX; Du LL; Zhao N; Dong Q; Liao YH; Du YM
    J Ethnopharmacol; 2013 Jul; 148(2):647-54. PubMed ID: 23707333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells.
    Leanza L; Henry B; Sassi N; Zoratti M; Chandy KG; Gulbins E; Szabò I
    EMBO Mol Med; 2012 Jul; 4(7):577-93. PubMed ID: 22496117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State-dependent blocking mechanism of Kv 1.3 channels by the antimycobacterial drug clofazimine.
    Faouzi M; Starkus J; Penner R
    Br J Pharmacol; 2015 Nov; 172(21):5161-73. PubMed ID: 26276903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vm24, a natural immunosuppressive peptide, potently and selectively blocks Kv1.3 potassium channels of human T cells.
    Varga Z; Gurrola-Briones G; Papp F; Rodríguez de la Vega RC; Pedraza-Alva G; Tajhya RB; Gaspar R; Cardenas L; Rosenstein Y; Beeton C; Possani LD; Panyi G
    Mol Pharmacol; 2012 Sep; 82(3):372-82. PubMed ID: 22622363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory effects of diclofenac in leukocytes through the targeting of Kv1.3 voltage-dependent potassium channels.
    Villalonga N; David M; Bielańska J; González T; Parra D; Soler C; Comes N; Valenzuela C; Felipe A
    Biochem Pharmacol; 2010 Sep; 80(6):858-66. PubMed ID: 20488163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The toxin mimic FS48 from the salivary gland of Xenopsylla cheopis functions as a Kv1.3 channel-blocking immunomodulator of T cell activation.
    Zeng Q; Lu W; Deng Z; Zhang B; Wu J; Chai J; Chen X; Xu X
    J Biol Chem; 2022 Jan; 298(1):101497. PubMed ID: 34919963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of the Kv1.3 K+ Channel Enhances BCG Vaccine Efficacy by Expanding Central Memory T Lymphocytes.
    Singh DK; Dwivedi VP; Ranganathan A; Bishai WR; Van Kaer L; Das G
    J Infect Dis; 2016 Nov; 214(9):1456-1464. PubMed ID: 27571906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent suppression of Kv1.3 potassium channel and IL-2 secretion by diphenyl phosphine oxide-1 in human T cells.
    Zhao N; Dong Q; Du LL; Fu XX; Du YM; Liao YH
    PLoS One; 2013; 8(5):e64629. PubMed ID: 23717641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation.
    Beeton C; Barbaria J; Giraud P; Devaux J; Benoliel AM; Gola M; Sabatier JM; Bernard D; Crest M; Béraud E
    J Immunol; 2001 Jan; 166(2):936-44. PubMed ID: 11145670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of CCR7(-) effector memory T cell activation by a novel peptide targeting Kv1.3 channel in a rat experimental autoimmune encephalomyelitis model.
    Li Z; Liu WH; Han S; Peng BW; Yin J; Wu YL; He XH; Li WX
    J Biol Chem; 2012 Aug; 287(35):29479-94. PubMed ID: 22761436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of Kv1.3 potassium channels inhibits differentiation and granzyme B secretion of human CD8+ T effector memory lymphocytes.
    Hu L; Wang T; Gocke AR; Nath A; Zhang H; Margolick JB; Whartenby KA; Calabresi PA
    PLoS One; 2013; 8(1):e54267. PubMed ID: 23382885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Inflammatory Effect of Licochalcone A via Regulation of ORAI1 and K
    Phan HTL; Kim HJ; Jo S; Kim WK; Namkung W; Nam JH
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis of a potent peptide inhibitor designed for Kv1.3 channel, a therapeutic target of autoimmune disease.
    Han S; Yi H; Yin SJ; Chen ZY; Liu H; Cao ZJ; Wu YL; Li WX
    J Biol Chem; 2008 Jul; 283(27):19058-65. PubMed ID: 18480054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis--xenograft model.
    Kundu-Raychaudhuri S; Chen YJ; Wulff H; Raychaudhuri SP
    J Autoimmun; 2014 Dec; 55():63-72. PubMed ID: 25175978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression by N-methyl-D-aspartate receptor antagonists is mediated through inhibition of Kv1.3 and KCa3.1 channels in T cells.
    Kahlfuß S; Simma N; Mankiewicz J; Bose T; Lowinus T; Klein-Hessling S; Sprengel R; Schraven B; Heine M; Bommhardt U
    Mol Cell Biol; 2014 Mar; 34(5):820-31. PubMed ID: 24344200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.